Clinical Trial: EGO-COMBO Clinical End-point Extension Study Beyond 36 Months

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Evaluation of Endothelial ProGenitor Cell Capture Sirolimus-Eluting Stent by Optical Coherence Tomography: the COMBO Stent 36-months Clinical End-point Extension Study (EGO-COMBO Clinical End-point Ex

Brief Summary: In this study, the safety and efficacy of COMBO TM stent beyond 36 months are assessed, in particular the occurrence of late stent thrombosis and late loss catch-up (restenosis).